IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease
- PMID: 24407884
- PMCID: PMC3984969
- DOI: 10.1189/jlb.0913482
IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease
Abstract
One of the most severe pathologic responses of RSV infection is associated with overproduction of cytokines and inflammation, leading to mucus hypersecretion. This study investigated the role of IL-25 in the development of RSV-associated immunopathology. IL-25 and its receptor IL-17RB were increased following RSV infection, and IL-25 blockade using neutralizing antibodies reduced RSV-associated pathology, AHR, and type 2 cytokine production. Likewise, IL-17RB-/- mice demonstrated a modified inflammatory response during RSV infection characterized by decreased Th2 and increased Th17 cytokine production. Additionally, the IL-17RB-/- mice demonstrated significantly reduced inflammation and cytokine production in a model of RSV-driven asthma exacerbation. These results indicate that IL-25 regulates the inflammatory response to RSV infection and that its inhibition may enable a reduction in the severity of RSV-associated pulmonary inflammation, including during viral-induced asthma exacerbation.
Keywords: Th2; cytokines; mucus.
© 2014 Society for Leukocyte Biology.
Figures
Similar articles
-
IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis.Am J Pathol. 2014 Jun;184(6):1807-18. doi: 10.1016/j.ajpath.2014.02.004. Epub 2014 Apr 13. Am J Pathol. 2014. PMID: 24726498 Free PMC article.
-
IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection.Scand J Immunol. 2015 Jun;81(6):494-501. doi: 10.1111/sji.12284. Scand J Immunol. 2015. PMID: 25721734
-
IL-4Rα on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection.J Leukoc Biol. 2017 Jul;102(1):153-161. doi: 10.1189/jlb.4A1216-536R. Epub 2017 Apr 7. J Leukoc Biol. 2017. PMID: 28389622 Free PMC article.
-
Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.Virus Genes. 2006 Oct;33(2):235-52. doi: 10.1007/s11262-006-0064-x. Virus Genes. 2006. PMID: 16972040 Review.
-
Th17 lymphocytes in respiratory syncytial virus infection.Viruses. 2013 Mar 5;5(3):777-91. doi: 10.3390/v5030777. Viruses. 2013. PMID: 23462708 Free PMC article. Review.
Cited by
-
The Maresin 1-LGR6 axis decreases respiratory syncytial virus-induced lung inflammation.Proc Natl Acad Sci U S A. 2023 Jan 10;120(2):e2206480120. doi: 10.1073/pnas.2206480120. Epub 2023 Jan 3. Proc Natl Acad Sci U S A. 2023. PMID: 36595677 Free PMC article.
-
Innate Type 2 Responses to Respiratory Syncytial Virus Infection.Viruses. 2020 May 8;12(5):521. doi: 10.3390/v12050521. Viruses. 2020. PMID: 32397226 Free PMC article. Review.
-
Robust induction of interferon and interferon-stimulated gene expression by influenza B/Yamagata lineage virus infection of A549 cells.PLoS One. 2020 Apr 8;15(4):e0231039. doi: 10.1371/journal.pone.0231039. eCollection 2020. PLoS One. 2020. PMID: 32267861 Free PMC article.
-
IL-17RB+ granulocytes are associated with airflow obstruction in asthma.Ann Allergy Asthma Immunol. 2016 Dec;117(6):674-679. doi: 10.1016/j.anai.2016.09.448. Ann Allergy Asthma Immunol. 2016. PMID: 27979026 Free PMC article.
-
The potential roles of interleukin-25 in infectious diseases.Front Immunol. 2022 Sep 2;13:986118. doi: 10.3389/fimmu.2022.986118. eCollection 2022. Front Immunol. 2022. PMID: 36119076 Free PMC article. Review.
References
-
- Szabo S. M., Levy A. R., Gooch K. L., Bradt P., Wijaya H., Mitchell I. (2013) Elevated risk of asthma after hospitalization for respiratory syncytial virus infection in infancy. Paediatr. Respir. Rev. 13 (Suppl. 2), S9–S15 - PubMed
-
- Hall C. B. (2012) The burgeoning burden of respiratory syncytial virus among children. Infect. Disord. Drug Targets 12, 92–97 - PubMed
-
- Habibi M. S., Openshaw P. J. (2012) Benefit and harm from immunity to respiratory syncytial virus: implications for treatment. Curr. Opin. Infect. Dis. 25, 687–694 - PubMed
-
- Elliot A. J., Fleming D. M. (2008) Influenza and respiratory syncytial virus in the elderly. Expert Rev. Vaccines 7, 249–258 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
